forecasted
Martin Delaney Collaboratories for HIV Cure Research
National Institutes of Health · FOR-AI-27-001
See source for award amount
Not specified
State governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), Public and State controlled institutions of higher education, For profit organizations other than small businesses, Native American tribal governments (Federally recognized), Small businesses, Independent school districts, Public housing authorities/Indian housing authorities, County governments, Private institutions of higher education
Geographic eligibility and all attachment-specific conditions require review of the original announcement.
Matching funds & resources
Source matching-funds field: Not Required.
Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy, with an ultimate goal of completely eradicating HIV reservoirs from the individual. The program will also address the unique needs of children living with HIV. The MDC program will accelerate HIV cure research by fostering strategic collaborations among academic institutions, scientists in government, the private sector, and community stakeholders. The program provides economies of scale by leveraging shared reagents, research resources, and specialized technologies in support of basic, translational, and clinical research. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Funding geography: Not specified — review source. A funder’s address does not establish eligibility.
Review original source ↗Funding instrument: Cooperative Agreement. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.
Source fields and evidence
id: 359663
Source ↗ · id
opportunityNumber: FOR-AI-27-001
Source ↗ · opportunityNumber
opportunityTitle: Martin Delaney Collaboratories for HIV Cure Research
Source ↗ · opportunityTitle
revision: 0
Source ↗ · revision
agencyDetails: {"code":"NIH","seed":"HHS-NIH11","agencyName":"National Institutes of Health","agencyCode":"HHS-NIH11","topAgencyCode":"HHS"}
Source ↗ · agencyDetails
owningAgencyCode: HHS-NIH11
Source ↗ · owningAgencyCode
cfdas: [{"id":429535,"opportunityId":359663,"cfdaNumber":"93.855","programTitle":"Allergy and Infectious Diseases Research"}]
Source ↗ · cfdas
forecastDesc: <p><span style="color: rgb(51, 51, 51);">The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for the Martin Delaney Collaboratories (MDCs) for HIV Cure Research. The goal of the MDC program is to develop strategies to control viral replication without the need for lifelong antiretroviral therapy, with an ultimate goal of completely eradicating HIV reservoirs from the individual. The program will also address the unique needs of children living with HIV. The MDC program will accelerate HIV cure research by fostering strategic collaborations among academic institutions, scientists in government, the private sector, and community stakeholders. The program provides economies of scale by leveraging shared reagents, research resources, and specialized technologies in support of basic, translational, and clinical research. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.</span></p>
Source ↗ · forecastDesc
applicantTypes: [{"id":"00","description":"State governments"},{"id":"12","description":"Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education"},{"id":"11","description":"Native American tribal organizations (other than Federally recognized tribal governments)"},{"id":"06","description":"Public and State controlled institutions of higher education"},{"id":"22","description":"For profit organizations other than small businesses"},{"id":"07","description":"Native American tribal governments (Federally recognized)"},{"id":"23","description":"Small businesses"},{"id":"05","description":"Independent school districts"},{"id":"08","description":"Public housing authorities/Indian housing authorities"},{"id":"01","description":"County governments"},{"id":"20","description":"Private institutions of higher education"}]
Source ↗ · applicantTypes
fundingInstruments: [{"id":"CA","description":"Cooperative Agreement"}]
Source ↗ · fundingInstruments
fundingActivityCategories: [{"id":"HL","description":"Health"}]
Source ↗ · fundingActivityCategories
costSharing: false
Source ↗ · costSharing
lastUpdatedDate: Jun 10, 2025 09:55:38 AM EDT
Source ↗ · lastUpdatedDate
status: forecasted
Source ↗ · oppHits[id=359663].oppStatus
Build your funding pipeline.
Save opportunities, filter by fit, and export your deadlines with membership.
View plans from $49/month ↗